Nurix Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-11-30 | 2024-08-31 | 2024-05-31 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 6.3M | 13.6M | 7.9M | 44.1M | 18.5M | 13.3M | 12.6M | 12.1M |
| Cost of Goods Sold | 84.1M | 4.6M | 5.0M | 78.1M | 69.7M | 67.2M | 55.5M | 48.9M |
| Gross Profit | -77.9M | 8.9M | 2.9M | -34.0M | -51.2M | -53.9M | -42.9M | -36.8M |
| R&D Expenses | 0 | 80.9M | 86.1M | 78.1M | 69.7M | 67.2M | 55.5M | 48.9M |
| Operating Expenses | 14.6M | 92.0M | 94.3M | 14.3M | 11.7M | 10.7M | 11.7M | 11.7M |
| Operating Income | -92.5M | -83.1M | -91.4M | -48.3M | -62.9M | -64.7M | -54.6M | -48.5M |
| Other Income / Gains | 5.3M | 4.9M | 5.0M | 5.6M | 6.5M | 6.1M | 5.7M | 4.1M |
| Net Income | -87.2M | -78.2M | -86.4M | -43.5M | -56.4M | -58.5M | -49.0M | -44.5M |
| EPS (Diluted) | -0.79 | -0.82 | -1.03 | -0.52 | -0.67 | -0.75 | -0.67 | -0.71 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | -12.458 | 0.659 | 0.367 | -0.773 | -2.775 | -4.061 | -3.407 | -3.046 |
| General And Administrative Expenses | 14.6M | 13.6M | 13.2M | 14.3M | 11.7M | 10.7M | 11.7M | 11.7M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 14.6M | 13.6M | 13.2M | 14.3M | 11.7M | 10.7M | 11.7M | 11.7M |
| Other Expenses | 0 | -2.5M | -5.0M | -78.1M | -69.7M | -67.2M | -55.5M | -48.9M |
| Cost And Expenses | 98.7M | 96.7M | 99.3M | 92.4M | 81.3M | 77.9M | 67.2M | 60.6M |
| Interest Income | 0 | 4.9M | 5.0M | 5.6M | 6.5M | 6.1M | 5.7M | 4.1M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 0 | 9.3M | 5.0M | 2.2M | 2.4M | 1.2M | 2.4M | 2.3M |
| Ebitda | -87.2M | -69.0M | -81.4M | -40.5M | -54.0M | -57.3M | -46.5M | -42.1M |
| Ebitdaratio | -13.943 | -5.079 | -10.314 | -0.918 | -2.926 | -4.313 | -3.692 | -3.484 |
| Operating Income Ratio | -14.794 | -6.12 | -11.577 | -1.097 | -3.407 | -4.867 | -4.338 | -4.014 |
| Income Before Tax | -87.2M | -78.2M | -86.4M | -42.7M | -56.4M | -58.5M | -48.9M | -44.5M |
| Income Before Tax Ratio | -13.943 | -5.761 | -10.948 | -0.969 | -3.054 | -4.407 | -3.883 | -3.676 |
| Income Tax Expense | 0 | 0 | 0 | 760K | 0 | 8K | 82K | 90K |
| Net Income Ratio | -13.943 | -5.761 | -10.948 | -0.987 | -3.054 | -4.407 | -3.889 | -3.684 |
| Epsdiluted | -0.79 | -0.82 | -1.03 | -0.52 | -0.67 | -0.75 | -0.67 | -0.71 |
| Weighted Average Shs Out | 110.1M | 95.1M | 84.2M | 83.9M | 83.6M | 78.4M | 72.8M | 62.4M |
| Weighted Average Shs Out Dil | 110.1M | 95.1M | 84.2M | 83.9M | 83.6M | 78.4M | 72.8M | 62.4M |